The Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) stock price has dropped 44% year to date and nearly 80% over the last three months.... The Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) stock price ...

Valeant stock is down again, and it's year-to-date losses have now topped 82%.

Valeant Pharmaceuticals Inc. sustained hits on several fronts on Thursday after CVS Health Corp. and Express Scripts dropped Philidor from their networks in a sign the fallout from the drugmaker's ...

(Reuters) - T. Rowe Price Group Inc has sued Valeant Pharmaceuticals International Inc , alleging that investors in the Canadian drugmaker lost billions of dollars as a result of the company's ...